MeVis Medical Solutions AG (M3V.DE) Stock Price
€25 0%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
7 -
Technical
7
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on MeVis Medical Solutions AG, AI stock picks, stock alerts and much more.
M3V.DE AI Stock Analysis
AI stock analysis for M3V.DE is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like MeVis Medical Solutions AG (M3V.DE) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
MeVis Medical Solutions AG (M3V.DE) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of MeVis Medical Solutions AG (M3V.DE), currently trading at €25, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About M3V.DE
-
MeVis Medical Solutions AG develops, markets, and sells software for analyzing and evaluating image data to equipment manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe.
-
Symbol
M3V.DE
-
Market
XETRA
-
Industry
Medical - Healthcare Information Services
-
Market Cap
45.5M
Similar Stocks
 |
Teladoc Health 4LL.F |
€6.4 1.6% |
5 |
 |
DocCheck AG AJ91.DE |
€11.7 0.00% |
6 |
 |
Nexus AG NXU.DE |
€70.8 0.8% |
7 |
 |
Oakridge International Limited U9O0.F |
€0.025 0.00% |
4 |
M3V.DE Alternative Data
Web Traffic
MeVis Medical Solutions AG receives an estimated 28562 monthly visitors to mevis.de.
-
Web Traffic
28562
-
Change from Previous Month
13.8%
-
3 Month Change
21.3%
-
YoY Change
21.3%
Youtube Subscribers
MeVis Medical Solutions AG has 154 subscribers on its main Youtube channel, up by 2.7% over the last month.
-
Youtube Subscribers
154
-
Daily Change
0%
-
1 Month Change
2.7%
-
3 Month Change
7.7%
Job Postings
MeVis Medical Solutions AG has an estimated 3 open job postings, which is down -40% over the last month.
-
Job Postings
3
-
Daily Change
0%
-
1 Month Change
40%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, MeVis Medical Solutions AG has 77 employees, down by -2.5% over the last month.
-
LinkedIn Employees
77
-
Daily Change
2.5%
-
1 Month Change
2.5%
-
3 Month Change
1.3%
Business Outlook
According to employee reviews, the business outlook among employees at MeVis Medical Solutions AG is 33 out of 100 (bearish).
-
Business Outlook
33
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
MeVis Medical Solutions AG was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
MeVis Medical Solutions AG has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
-
3 Month Change
0%
M3V.DE Financials
M3V.DE Key Metrics
-
Total Revenue
€8.8M
-
Net Income
€2.7M
-
Earnings per Share
€1.46
-
Free cash flow
€0
-
EBITDA
€2.2M
-
EBITDA Ratio
0.255944
-
Total Assets
€26.5M
M3V.DE 2-year Revenue & Income
M3V.DE 2-year Free Cash Flow
M3V.DE Technicals
M3V.DE SMA
M3V.DE RSI
FAQ
What's the current price of MeVis Medical Solutions AG (M3V.DE) Stock?
The price of an MeVis Medical Solutions AG (M3V.DE) share is €25.
What's the market cap of MeVis Medical Solutions AG?
The current market cap of MeVis Medical Solutions AG is 45.5M.
Should I buy or sell M3V.DE?
MeVis Medical Solutions AG shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, MeVis Medical Solutions AG is better viewed as a hold or accumulate position while waiting for further developments.
Is MeVis Medical Solutions AG a good investment?
The current analysis of MeVis Medical Solutions AG's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in MeVis Medical Solutions AG's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy MeVis Medical Solutions AG (M3V.DE) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for MeVis Medical Solutions AG stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to MeVis Medical Solutions AG (M3V.DE) that investors often compare it to?
MeVis Medical Solutions AG (M3V.DE) is often compared to similar stocks such as Teladoc Health, DocCheck AG, Nexus AG and Oakridge International Limited.
What is the forecast for MeVis Medical Solutions AG's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast MeVis Medical Solutions AG's stock price to be around €25.33 in 2026. Starting from the current price of €25, this represents a 1.3% change in price, indicating a neutral outlook for the stock.
How to buy MeVis Medical Solutions AG (M3V.DE) Stock?
MeVis Medical Solutions AG stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy MeVis Medical Solutions AG shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.